First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma—A Retrospective Study

by Paul V. Viscuse, Katharine A. Price, Joaquin J. Garcia, David J. Schembri-Wismayer, Ashish V. Chintakuntlawar
Published 2019-08-01

Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Jo...

by Paul V. Viscuse, Mario L. Marques-Piubelli, Meghan M. Heberton, Edwin Roger Parra, Amishi Y. Shah, Arlene Siefker-Radtke, Jianjun Gao, Sangeeta Goswami, Doina Ivan, Jonathan L. Curry, Jonathan L. Curry, Matthew T. Campbell
Published 2021-03-01

Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments

by Paul V. Viscuse, Rebecca S. Slack-Tidwell, Miao Zhang, Prih Rohra, Keyi Zhu, F. Anthony San Lucas, Eric Konnick, Patrick G. Pilie, Bilal Siddiqui, Christopher J. Logothetis, Paul Corn, Sumit K. Subudhi, Colin C. Pritchard, Rama Soundararajan, Ana Aparicio
Published 2023-12-01